Monday, May 12, 2025
spot_img

NMI Holdings, Inc. to Announce First Quarter 2025 Financial Results on April 29, 2025

EMERYVILLE, Calif., April 11, 2025 (GLOBE NEWSWIRE) — NMI Holdings, Inc., (NASDAQ: NMIH), the parent company of National Mortgage Insurance Corporation (National MI), today announced that it will report results for its first quarter ended March 31, 2025 after the market close on Tuesday, April 29, 2025.

The company will hold a conference call and live webcast at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time. The webcast will be available on the company’s website at https://ir.nationalmi.com/events-and-presentations. The call can be accessed by dialing (844) 481-2708 in the U.S. or (412) 317-0664 internationally by referencing NMI Holdings, Inc.

A replay of the webcast as well as the earnings press release and any supplemental information will be available on the company’s website.

About NMI Holdings

NMI Holdings, Inc. (NASDAQ: NMIH) is the parent company of National Mortgage Insurance Corporation (National MI), a U.S.-based, private mortgage insurance company enabling low-down-payment borrowers to realize home ownership while protecting lenders and investors against losses related to a borrower’s default. To learn more, please visit www.nationalmi.com.

Investor Contact
Gregory Epps
Senior Manager, Investor Relations and Treasury
[email protected]

Powered by SlickText.com

Hot this week

Orbit International Corp. Reports 2025 First Quarter Results

First Quarter 2025 Net Loss of $2,152,000 ($0.65 loss...

Share buy-back program

COMPANY ANNOUNCEMENT NO 26/2025 - May 12, 2025 ...

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2025

Conference Call Scheduled for Thursday, May 15, 2025 at...

Moleculin Receives European Medicines Agency Approval to Expand Phase 3 MIRACLE Clinical Trial

Adds nine additional countries to the Company’s ongoing pivotal...

Barnes & Noble Education Announces Surge in New Campus Store Partnerships

Over 20 new institutions across a mix of two-...

Topics

Orbit International Corp. Reports 2025 First Quarter Results

First Quarter 2025 Net Loss of $2,152,000 ($0.65 loss...

Share buy-back program

COMPANY ANNOUNCEMENT NO 26/2025 - May 12, 2025 ...

Moleculin Receives European Medicines Agency Approval to Expand Phase 3 MIRACLE Clinical Trial

Adds nine additional countries to the Company’s ongoing pivotal...

NeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical Advisor

Significant Neurological Expertise to Help Drive Clinical Development Strategy and...
spot_img

Related Articles

Popular Categories

spot_img